Clinicians are invited to participate in the Activating Primary Care COPD Patients with Multimorbidity (APCOM) Trial.
The APCOM Trial, funded by the Australian Government Medical Research Future Fund, is a primary health care implementation research study being conducted by Bond University, University of Queensland, UNSW Sydney, Woolcock Institute of Medical Research, University of Wollongong Australia, University of Sydney, Lung Foundation Australia, Australian Primary Health Care Nurses Association, and the Royal Australian College of General Practitioners.
The trial aims to improve the quality of life of patients with Chronic Obstructive Pulmonary Disease (COPD) and other chronic health conditions through an innovative practice nurse-led, tailored self-management program in Australian general practice.
Participation incentives
- All participating practices that recruit eligible patients for the trial will be recompensed $1000.
- A $200 gift voucher will be provided to a practice champion, nominated by the practice team, who will be the main focal point of the study.
- General practices allocated to the intervention arm of the trial will be provided a payment of $60/hour for the practice nurse’s time towards attending an online training workshop and delivery of the self-management program to participating patients in up to five personalised health coaching sessions.
- GPs and PNs can also claim CPD hours for their involvement in the trial.
For more information, visit https://www.goldnetresearch.com.au/apcom-trial.
If you are interested in participating or have any questions, please contact Professor Nick Zwar, Lead Investigator, on [email protected] or 07 5595 5499, or the trial manager Dr Sameera Ansari at [email protected]